Pseudotumor syndrome associated with cerebral venous sinus occlusion and antiphospholipid antibodies

Stroke

Volumn 24, Issue 3, 1993, Pages 469-472

  Mokri, Bahram ^a   Jack Jr , Clifford R ^a   Petty, George W ^a  

^a MAYO CLINIC   (United States)

Author keywords

Anticoagulants, antiphospholipid antibodies; Cerebrovascular disorders; Pseudotumor cerebri

Indexed keywords

ACETAZOLAMIDE; ACETYLSALICYLIC ACID; DIPYRIDAMOLE; FUROSEMIDE; PHOSPHOLIPID ANTIBODY; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BRAIN PSEUDOTUMOR; CASE REPORT; CEREBROSPINAL FLUID EXAMINATION; CEREBROSPINAL FLUID PRESSURE; CEREBROVASCULAR DISEASE; DIFFERENTIAL DIAGNOSIS; HUMAN; INTRACRANIAL PRESSURE; LUMBAR PUNCTURE; MALE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; PAPILLEDEMA; PHLEBOGRAPHY; PRIORITY JOURNAL; VEIN THROMBOSIS; VISUAL DISORDER;

ACETAZOLAMIDE; ANTIBODIES, ANTIPHOSPHOLIPID; CASE REPORT; CEREBRAL ANGIOGRAPHY; CEREBRAL VEINS; HEARING LOSS, NOISE-INDUCED; HUMAN; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGE; PAPILLEDEMA; PSEUDOTUMOR CEREBRI; THROMBOPHLEBITIS; WARFARIN;

EID: 0027403737     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.24.3.469     Document Type: Article

References (37)

1. Ahlskog JE, O'Neill BJ: Pseudotumor cerebri. Ann Intern Med 1982;97:249-256
2. Johnston I, Paterson A: Benign intracranial hypertension: I. Diagnosis and prognosis. Brain 1974;97:289-300
3. Lepore FE: Unilateral and highly asymmetric papilledema in pseudotumor cerebri. Neurology 1992;42:676-678
4. Marcelis J, Silberstein SD: Idiopathic intracranial hypertension without papilledema. Arch Neural 1991;48:392-399
5. Johnston I, Hawke S, Halmagyi M, Teo C: The pseudotumor syndrome: Disorders of cerebrospinal fluid circulation causing intracranial hypertension without ventriculomegaly. Arch Neurol 1991;48:740-747
6. Sack GH Jr, Levin J, Bell WR: Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: Clinical, pathophysiologic, and therapeutic features. Medicine 1977;56:1-37
7. Sun NCJ, McAfee WM, Hum GJ, Weiner JM: Hemostatic abnormalities in malignancy, a prospective study of one hundred eight patients: Part I. Coagulation studies. Am J Clin Pathol 1979;71: 10-16
8. Haemostatic abnormalities and malignant disease. (editorial) Lancet 1986;I:303-304
9. Vidailhet M, Piette J-C, Wechsler B, Bousser M-G, Brunet P: Cerebral venous thrombosis in systemic lupus erythematosus. Stroke 1990;21:1226-1231
10. Wechsler B, Vidailhet M, Piette JC, Bousser MG, Dell Isola B, Blétry O, Godeau P: Cerebral venous thrombosis in Behçet's disease: Clinical study and long-term follow-up of 25 cases. Neurology 1992;42:614-618
11. Kitchens CS: Concept of hypercoagulability: A review of its development, clinical application, and recent progress. Semin Thromb Hemost 1985;11:293-315
12. Schutta HS, Williams EC, Baranski BG, Sutula TP: Cerebral venous thrombosis with piasminogen deficiency. Stroke 1991;22: 401-405
13. Cros D, Comp PC, Beltran G, Gum G: Superior sagittal sinus thrombosis in a patient with protein S deficiency. Stroke 1990;21: 633-636
14. Bousser M-G, Chiras J, Bories J, Castaigne P: Cerebral venous thrombosis: A review of 38 cases. Stroke 1985;16:199-213
15. Ambruso DR, Jacobson LJ, Hathaway WE: Inherited antithrombin III deficiency and cerebral thrombosis in a child. Pediatrics 1980;65:125-131
16. Tarras S, Gadia C, Meister L, Roldan E, Gregorios JB: Homozygous protein C deficiency in a newborn: Clinicopathologic correlation. Arch Neural 1988;45:214-216
17. Levine SR, Kieran S, Puzio K, Feit H, Patel SC, Welch KMA: Cerebral venous thrombosis with lupus anticoagulants: Report of two cases. Stroke 1987;18:801-804
18. Ford SE, Lillicrap D, Brunet D, Ford P: Thrombotic endocarditis and lupus anticoagulant: A pathogenetic possibility for idiopathic 'rheumatic type' valvular heart disease. Arch Pathol Lab Med 1989; 113:350-353
19. Harris EN: Serological detection of antiphospholipid antibodies. Stroke 1992;23(suppl I):I-3-I-6
20. Levine SR, Deegan MJ, Futrell N, Welch KMA: Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases. Neurology 1990;40:1181-1189
21. Brey RL, Hart RG, Sherman DG, Tegeler CH: Antiphospholipid antibodies and cerebral ischemia in young people. Neurology 1990; 40:1190-1196
22. Hess DC: Stroke associated with antiphospholipid antibodies. Stroke 1992;23(suppl I):I-23-I-28
23. Digre KB, Durcan FJ, Branch DW, Jacobson DM, Varner MW, Baringer JR: Amaurosis fugax associated with antiphospholipid antibodies. Ann Neurol 1989;25:228-232
24. Kleiner RC, Najarian LV, Schatten S, Jabs DA, Patz A, Kaplan HJ: Vaso-occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy). Ophthalmology 1989; 96:896-904
25. Briley DP, Coull BM, Goodnight SH Jr: Neurological disease associated with antiphospholipid antibodies. Ann Neural 1989;25: 221-227
26. Inzelberg R, Korczyn AD: Lupus anticoagulant and late onset seizures. Acta Neural Scand 1989;79:114-118
27. Coull BM, Bourdette DN, Goodnight SH Jr, Briley DP, Hart R: Multiple cerebral infarctions and dementia associated with anticardiolipin antibodies. Stroke 1987;18:1107-1112
28. Asherson RA, Mercey D, Phillips G, Sheehan N, Gharavi AE, Harris EN, Hughes GRV: Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: Association with antiphospholipid antibodies. Ann Rheum Dis 1987;46:605-611
29. Khamashta MA, Gil A, Anciones B, Lavilla P, Valencia ME, Pintado V, Vázquez JJ: Chorea in systemic lupus erythematosus: Association with antiphospholipid antibodies. Ann Rheum Dis 1988;47:681-683
30. Asherson RA, Derksen RHWM, Harris EN, Bouma BN, Gharavi AE, Kater L, Hughes GRV: Chorea in systemic lupus erythematosus and 'lupus-like' disease: Association with antiphospholipid antibodies. Semin Arthritis Rheum 1987;16:253-259
31. Lavalle C, Pizarro S, Drenkard C, Sánchez-Guerrero J, Alarcón-Segovia D: Transverse myelitis: A manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies. J Rheumatol 1990;17:34-37
32. Asherson RA, Khamashta MA, Gil A, Vazquez JJ, Chan O. Baguley E, Hughes GR: Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med 1989;86: 391-399
33. Shuaib A, Barklay L, Lee MA, Suchowersky O: Migraine and antiphospholipid antibodies. Headache 1989;29:42-45
34. Levine SR, Joseph R, D'Andrea G, Welch KMA: Migraine and the lupus anticoagulant: Case reports and review of the literature. Cephalalgia 1987;7:93-99
35. Hogan MJ, Brunet DG, Ford PM, Lillicrap D: Lupus anticoagulant, antiphospholipid antibodies and migraine. Can J Neural Sci 1988;15:420-425
36. Levine SR, Langer SL, Albers JW, Welch KMA: Sneddon's syndrome: An antiphospholipid antibody syndrome? Neurology 1988; 38:798-800
37. Kalashnikova LA, Nasonov EL, Kushekbaeva AE, Gracheva LA: Anticardiolipin antibodies in Sneddon's syndrome. Neurology 1990;40:464-467